Skip to main content
Current Developments in Nutrition logoLink to Current Developments in Nutrition
. 2019 Jun 13;3(Suppl 1):nzz039.OR33-01-19. doi: 10.1093/cdn/nzz039.OR33-01-19

A Meta-analysis of Vitamin K Status and Cardiovascular Disease (OR33-01-19)

M Kyla Shea 1, Daniel Weiner 2, Gregory Matuszek 1, Sarah Booth 2, Kathryn Barger 1
PMCID: PMC6573948

Abstract

Objectives

Evidence suggests low vitamin K status may be associated with an increased cardiovascular disease (CVD) risk in people with CVD risk factors. The objective of this study was to summarize the association between vitamin K status and CVD, overall and according to baseline CVD risk, by conducting a participant-level meta-analysis using data from the Framingham Offspring Study, the Health, Aging, and Body Composition Study (Health ABC), and the Multi-ethnic Study of Atherosclerosis (MESA).

Methods

Circulating phylloquinone (vitamin K1), measured from baseline fasting blood samples, was categorized as ≤0.5 nM, >0.5 - ≤1.0 nM and >1.0 nM. CVD was defined as confirmed ischemic heart disease, angina, resuscitated cardiac arrest, fatal or non-fatal myocardial infarction or stroke. Multivariable Cox proportional hazards models were used to evaluate the association between circulating phylloquinone and incident CVD overall and stratified according to baseline CVD risk factors.

Results

Among the 3622 participants (mean (SD) baseline age 65 (11), 45% men, 65% white), there were 785 CVD events over a median of 13.0 years. Overall the risk for CVD did not differ significantly according to circulating phylloquinone categories [HR(95%CI) for CVD, compared to plasma phylloquinone >1.0 nM: ≤0.5 nM = 1.15 (0.96–1.38); >0.5 - ≤1.0 nM = 0.99 (0.84–1.18)]. However, lower circulating phylloquinone was associated with higher incident CVD risk in those with diabetes, with a normal BMI, and in women (Table).

Conclusions

Overall, we did not detect any significant differences in CVD risk across circulating phylloquinone categories in community-dwelling adults. However, low circulating phylloquinone was associated with a higher CVD risk among certain sub-groups, but additional studies are needed to clarify if improving vitamin K status will benefit the cardiovascular health of certain segments of the population.

Funding Sources

Supported by NHLBI R21HL133421 and the USDA ARS Cooperative Agreement (58‐1950‐7‐707).

Supporting Tables, Images and/or Graphs

graphic file with name nzz039fig15.jpg


Articles from Current Developments in Nutrition are provided here courtesy of American Society for Nutrition

RESOURCES